Poseida Therapeutics, Inc. (PSTX)

Poseida Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	246	321	456	426	678	-
Market Cap Growth	85.38%	-29.47%	7.02%	-37.23%	-	-
Enterprise Value	86	169	267	288	396	-
Last Close Price	2.47	3.36	5.30	6.81	10.97	-
PE Ratio	-	-2.45	-5.96	-3.39	-3.04	-
PS Ratio	2.66	4.97	3.49	13.63	-	-
PB Ratio	3.94	3.10	2.43	2.72	2.59	-
P/FCF Ratio	1131.54	-3.37	-14.84	-4.05	-5.21	-
P/OCF Ratio	97.55	-3.49	-17.02	-4.15	-5.98	-
EV/Sales Ratio	0.97	2.61	2.05	9.22	-	-
EV/EBITDA Ratio	-1.50	-1.36	-4.88	-2.10	-3.19	-
EV/EBIT Ratio	-1.43	-1.30	-4.46	-2.04	-3.13	-
EV/FCF Ratio	404.38	-1.77	-8.70	-2.74	-3.04	-
Debt / Equity Ratio	1.38	0.82	0.47	0.39	0.24	0.43
Debt / FCF Ratio	394.59	-0.90	-2.89	-0.58	-0.47	-0.45
Asset Turnover	0.31	0.21	0.42	0.10	-	-
Quick Ratio	2.44	3.10	5.41	4.76	10.30	5.73
Current Ratio	2.48	3.18	5.54	4.94	10.46	5.82
Return on Equity (ROE)	-115.00%	-84.75%	-37.23%	-59.77%	-77.27%	-242.83%
Return on Assets (ROA)	-25.54%	-25.87%	-12.06%	-27.59%	-30.51%	-51.30%
Return on Capital (ROIC)	-40.37%	-34.78%	-15.18%	-32.66%	-36.84%	-80.79%
Earnings Yield	-47.01%	-38.42%	-14.05%	-29.36%	-19.14%	-
FCF Yield	0.09%	-29.64%	-6.74%	-24.71%	-19.20%	-
Buyback Yield / Dilution	-13.42%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%
Total Shareholder Return	-13.42%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%

Source: S&P Capital IQ. Standard template. Financial Sources.